OBJECTIVES: To understand the disease epidemiology of syphilis in pregnant women, and to evaluate the effectiveness of the screening and intervention programme, for the purpose of controlling mother-to-child syphilis transmission in Shenzhen, in the People's Republic of China (PRC). METHODS: At the Shenzhen Center for Disease Control and Prevention (SZCDC), we used the toluidine red unheated serum test (TRUST) for the primary screening of pregnant women, and confirmed positive results with the Treponema pallidum particle agglutination (TPPA) test. We informed and treated those with positive results. For the women who chose to proceed with the pregnancy, we clinically screened their babies for congenital syphilis using the 19S-IgM FTA-Abs test. RESULTS: Between 1 July 2002 and 31 December 2005, we screened 477,656 pregnant women for syphilis, of whom 2208 (0.5%) tested positive. From 2003 to 2005, we collected epidemiological and treatment data from 2019 positive syphilis cases. Of these, 1855 (91.9%) of the pregnant women received treatment. Among the 1020 infants born to these women, 92 (9.0%) were confirmed to have congenital syphilis. If we exclude the mothers who had syphilis positive babies without undergoing prenatal screening, the project's success rate for mother-to-child transmission intervention was 99.1%. CONCLUSIONS: After four years of implementation, we proved the programme to be successful in preventing mother-to-child syphilis transmission. Further work should be done to ensure the earlier screening and treatment of pregnant women.
OBJECTIVES: To understand the disease epidemiology of syphilis in pregnant women, and to evaluate the effectiveness of the screening and intervention programme, for the purpose of controlling mother-to-child syphilis transmission in Shenzhen, in the People's Republic of China (PRC). METHODS: At the Shenzhen Center for Disease Control and Prevention (SZCDC), we used the toluidine red unheated serum test (TRUST) for the primary screening of pregnant women, and confirmed positive results with the Treponema pallidum particle agglutination (TPPA) test. We informed and treated those with positive results. For the women who chose to proceed with the pregnancy, we clinically screened their babies for congenital syphilis using the 19S-IgM FTA-Abs test. RESULTS: Between 1 July 2002 and 31 December 2005, we screened 477,656 pregnant women for syphilis, of whom 2208 (0.5%) tested positive. From 2003 to 2005, we collected epidemiological and treatment data from 2019 positive syphilis cases. Of these, 1855 (91.9%) of the pregnant women received treatment. Among the 1020 infants born to these women, 92 (9.0%) were confirmed to have congenital syphilis. If we exclude the mothers who had syphilis positive babies without undergoing prenatal screening, the project's success rate for mother-to-child transmission intervention was 99.1%. CONCLUSIONS: After four years of implementation, we proved the programme to be successful in preventing mother-to-child syphilis transmission. Further work should be done to ensure the earlier screening and treatment of pregnant women.
Authors: F Terris-Prestholt; D Watson-Jones; K Mugeye; L Kumaranayake; L Ndeki; H Weiss; J Changalucha; J Todd; F Lisekie; B Gumodoka; D Mabey; R Hayes Journal: Sex Transm Infect Date: 2003-10 Impact factor: 3.519
Authors: Li-Gang Yang; Joseph D Tucker; Cheng Wang; Song-Ying Shen; Xiang-Sheng Chen; Bin Yang; Rosanna Peeling Journal: Bull World Health Organ Date: 2011-09-27 Impact factor: 9.408
Authors: Joseph D Tucker; Sarah J Hawkes; Yue-Pin Yin; Rosanna W Peeling; Myron S Cohen; Xiang-Sheng Chen Journal: Bull World Health Organ Date: 2010-06 Impact factor: 9.408
Authors: Li-Gang Yang; Joseph D Tucker; Feng-Ying Liu; Xu-Qi Ren; Xuan Hong; Cheng Wang; Megan M McLaughlin; Cedric H Bien; Xiang-Sheng Chen; Bin Yang Journal: PLoS One Date: 2013-08-29 Impact factor: 3.240